Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 61 Stomach Neoplasms 46 Carcinoma, Non-Small-Cell Lung 37 Colorectal Neoplasms 24 Esophageal Squamous Cell Carcinoma 19 Lung Neoplasms 12 Rectal Neoplasms 11 Nasopharyngeal Carcinoma 11 Esophageal Neoplasms 11 Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Pancreatic Neoplasms 7 Neoplasm Metastasis 7 Cholangiocarcinoma 6 Uterine Cervical Neoplasms 5 Small Cell Lung Carcinoma 5 Liver Neoplasms 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Endometrial Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Renal Cell 4 Solid Tumor 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Extranodal NK-T-Cell 3 Colorectal Cancer Metastatic 3 Carcinoma 3 Breast Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3

Interventions

Cetuximab 2 Alpelisib 2 toripalimab 1 sintilimab 1 rocakinogene sifuplasmid 1 raltitrexed 1 cabozantinib 1 VGX-3100 1 Radiotherapy, Intensity-Modulated 1 Metformin 1 MEDI0457 1 Fluorouracil 1 Cisplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Squamous Cell Cancer × sintilimab × Clear all

NCT03975270 2019-07-18

HNSCC

ChineseAMS

Phase 2 Unknown

Head and Neck Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡